Increased engraftment of hepatic progenitors after activation of the hepatocyte growth factor signaling pathway by protein transduction

Experimental Biology and Medicine

Volumn 234, Issue 9, 2009, Pages 1102-1108

  Kellermann, Guillaume ^a   Boudechiche, Lyes ^a   Weber, Anne ^a   Hadchouel, Michelle ^a  

^a INSERM   (France)

Author keywords

Hepatocyte transplantation; HGF; Protein transduction; TAT

Indexed keywords

CELL SURFACE RECEPTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TAT TPR MET PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; ENGRAFTMENT; LIVER CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FOLDING; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL LINE; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; MICE; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70349138910     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-32     Document Type: Article

References (30)

1. Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2:205-213, 2008. (Pubitemid 351298597)
2. Fiaschi-Taesch N, Stewart AF, Garcia-Ocana A. Improving islet transplantation by gene delivery of hepatocyte growth factor (HGF) and its downstream target, protein kinase B (PKB)/Akt. Cell Biochem Biophys 48:191-199, 2007. (Pubitemid 47340886)
3. Garcia-Ocana A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera JC, Stewart AF. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-2762, 2001. (Pubitemid 33733126)
4. Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2:289-300, 2002. (Pubitemid 37328782)
5. Boccaccio C, Ando M, Comoglio PM. A differentiation switch for genetically modified hepatocytes. FASEB J 16:120-122, 2002.
6. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A 91:4731-4735, 1994. (Pubitemid 24177723)
7. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4:1449-1452, 1998. (Pubitemid 28553472)
8. Dietz GP, Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 27:85-131, 2004. (Pubitemid 39370094)
9. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836-5840, 2001. (Pubitemid 37385738)
10. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310-315, 2004.
11. Dean M, Park M, Vande Woude GF. Characterization of the rearranged tpr-met oncogene breakpoint. Mol Cell Biol 7:921-924, 1987. (Pubitemid 17004559)
12. Gonzatti-Haces M, Seth A, Park M, Copeland T, Oroszlan S, Vande Woude GF. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A 85:21-25, 1988.
13. Rodrigues GA, Park M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol 13:6711-6722, 1993. (Pubitemid 23321125)
14. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 8:995-1004, 2001. (Pubitemid 34031802)
15. Vigna E, Gramaglia D, Longati P, Bardelli A, Comoglio PM. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. Oncogene 18:4275-4281, 1999. (Pubitemid 29377859)
16. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925, 2003.
17. Peschard P, Park M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26:1276-1285, 2007.
18. Pastori RL, Klein D, Ribeiro MM, Ricordi C. Delivery of proteins and peptides into live cells by means of protein transduction domains: potential application to organ and cell transplantation. Transplantation 77:1627-1631, 2004. (Pubitemid 38780524)
19. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods 24:247-256, 2001. (Pubitemid 32846431)
20. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 98:1543-1548, 2001. (Pubitemid 32165535)
21. Jungbauer A, Kaar W, Schlegl R. Folding and refolding of proteins in chromatographic beds. Curr Opin Biotechnol 15:487-494, 2004. (Pubitemid 39304047)
22. Tsumoto K, Ejima D, Kumagai I, Arakawa T. Practical considerations in refolding proteins from inclusion bodies. Protein Expr Purif 28:1-8, 2003. (Pubitemid 36453171)
23. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099, 1994. (Pubitemid 24095017)
24. Li Y, Bhargava MM, Joseph A, Jin L, Rosen EM, Goldberg ID. Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol Anim 30A:105-110, 1994. (Pubitemid 24164789)
25. Medico E, Mongiovi AM, Huff J, Jelinek MA, Follenzi A, Gaudino G, Parsons JT, Comoglio PM. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7:495-504, 1996. (Pubitemid 26112558)
26. Strick-Marchand H, Morosan S, Charneau P, Kremsdorf D, Weiss MC. Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci U S A 101:8360-8365, 2004. (Pubitemid 38736580)
27. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med 138:298-312, 2001. (Pubitemid 33066152)
28. Joseph B, Malhi H, Bhargava KK, Palestro CJ, McCuskey RS, Gupta S. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 123:1677-1685, 2002. (Pubitemid 35231667)
29. Gupta S, Rajvanshi P, Sokhi R, Slehria S, Yam A, Kerr A, Novikoff PM. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29:509-519, 1999. (Pubitemid 29088456)
30. Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J Gastroenterol 44:167-172, 2009.